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Abstract
Background: Research on matching patients to treatment has shown that matching grounded in expert views is
little better than allocating patients by chance. Furthermore, there is growing emphasis on involving patients in
their own treatment as a key to health behavior change. Research on the benefit of having patients choose their
treatment from among options, in contrast to being assigned to a treatment by experts, has been limited.
Consequently, we designed a rigorous test of patient self-matching to determine whether it does improve
retention, adherence, and outcome in alcoholism treatment.
Methods/design: The present study is being conducted as a randomized controlled trial. Four hundred
consecutive patients aged 18 years or older will be enrolled and randomized to either self-matching or expert-
matching to one of five different treatment approaches. All patients entering the alcohol outpatient clinic in
Odense are offered the opportunity to participate in the study. Exclusion criteria are cognitive dysfunction as
measured with the Mini Mental State Examination, and non-Danish- or non-English-speaking individuals. The
following instruments will be administered at intake to provide standardized measures of alcohol problems: the
Addiction Severity Index, Timeline Followback, the World Health Organization quality of life questionnaire, the NEO
Five-Factor Inventory 3, and the Personal Happiness Form. For each outcome measure, two analyses will be
conducted. Intention-to-treat analyses (ITT) will be carried out with all patients, regardless of whether they complete
the interventions or are reinterviewed. Regarding incomplete data, multiple imputations will be used together with
ITT analysis. Completer analyses will also be carried out with patients who complete their respective interventions.
The primary outcome is decrease in number of monthly excessive drinking days 6 months after initiation of
treatment. Secondary outcomes are compliance and 2 quality of life. The influence of personality traits on outcome
will also be examined in both groups.
Discussion: The debate on matching patients to treatment has been going on for decades. This study will cast
light on this issue by focusing on patients’ choice and thereby clarifying if patients’ perceived autonomy yields
better outcomes.
Trial registration: ClinicalTrials.gov, NCT03278821. Registered on 12 September 2017.
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* Correspondence: mhell@health.sdu.dk
1Unit of Clinical Alcohol Research (UCAR), Institute of Clinical Research,
University of Southern Denmark, Odense, Denmark
2Odense Patient data Explorative Network (OPEN), Odense University
Hospital, Odense, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hell et al. Trials  (2018) 19:219 
https://doi.org/10.1186/s13063-018-2592-9
Background
International emphasis is growing on involving patients in
their own treatment as a key to health behavior change
and improved self-management of chronic diseases [1, 2].
The central concepts are that patients should take an ac-
tive role in choosing and implementing their own care
and that health care systems should actively support and
honor patients’ self-determination [3–5].
A related line of research in alcoholism treatment per-
tains to patient-treatment matching. On the basis of the
idea that different kinds of patients may respond differ-
ently to different treatment approaches, the U.S.
National Institute on Alcohol Abuse and Alcoholism
funded the largest randomized trial of alcoholism treat-
ment methods ever conducted: Project MATCH [6]. The
primary purpose of this project was to test matching
hypotheses regarding which patients would respond
optimally to three very different treatments: cognitive
behavioral therapy, 12-step facilitation therapy, and mo-
tivational enhancement therapy. The principal investiga-
tors of this trial, who were prominent alcoholism
treatment researchers in the United States, generated
two dozen a priori matching hypotheses. The project in-
cluded replication of nearly every matching effect that
had been reported in prior clinical trials [7] and repre-
sented top experts’ predictions regarding which patients
should be assigned to which treatments. The stunning
finding of Project MATCH was that even with a very
large sample size (N = 1726), very few of the hypotheses
were confirmed as statistically significant [8, 9]. Nearly
all previously reported matching effects failed to be con-
firmed, and several emerged in a direction opposite to
prediction. In a partial replication of the MATCH study,
the UK Alcohol Treatment Trial (UKATT) research
team conducted a pragmatic randomized trial with two
different treatment options [10]. They similarly found
improvement in alcohol consumption with all treatment
methods, with no difference between the groups or con-
firmation of matching predictions. In other words, the
best “guesses” of some of the field’s most experienced al-
coholism treatment researchers in two nations were little
better than chance when it came to choosing the best
treatment approaches for patients.
Another major attempt at expert matching was a set
of patient placement criteria promulgated by the
American Society of Addiction Medicine [11]. As it be-
came clear that the outcomes of inpatient programs
were no different, on average, from those of less costly
outpatient options [12], insurance companies dramatic-
ally reduced reimbursement for inpatient treatment. In
response, a group of treatment program directors in
northern Ohio developed a consensus set of decision
rules, known as the Cleveland criteria [13], to defend
the allocation of patients to particular levels of care.
These rules were subsequently published by the
American Society of Addiction Medicine [14] and were
then revised into even more complex decision systems
[15, 16]. Six types of data from an extensive evaluation
are used to recommend which of six levels of care a
patient should receive.
If an expert matching system such as this one is valid,
then patients who are matched to treatment on the basis
of these criteria should have better outcomes than those
who are mismatched. The few studies of these criteria to
date have provided little evidence for their efficacy. One
early study [17] demonstrated no significant improvement
in 6-month outcomes for matched versus mismatched
cases given outpatient treatment (level II, Cleveland cri-
teria). Similarly, only one of several potential matches was
statistically significant in another study of inpatient treat-
ment [18]. These studies were limited to evaluation of one
level of care. Four trials with patients receiving different
levels of care also found little support for this expert
matching system. Two of these reported only one “signifi-
cant” match of the many tested, with no Bonferroni cor-
rection for the number of hypotheses tested [19, 20]. The
third, a random assignment trial, found no significant
matches at all [21]. The fourth, a multicenter observa-
tional follow-up study, found that only 24.4% of patients
were matched properly to the treatment planned [22].
One naturalistic study in Norway [23] comparing only
two levels of care found that cases given less intensive
treatment than recommended showed higher attrition,
less improvement in severity, and no significant reduction
in substance use when compared with matched cases who
were offered the recommended level of care. In summary,
the findings are quite mixed, and once again, a complex
expert system for placing patients into the best treatment
for them appears to be little better than chance.
The difficulties experts have in matching patients to
treatment and developing useful algorithms have led
many researchers to question whether matching based
on patient characteristics is optimal for improving treat-
ment outcome [24, 25]. Are there other aspects of treat-
ment and treatment allocation that are more important?
If experts are not particularly good at deciding which al-
coholism treatment is best for patients, how else might
matching be done?
One option is, for instance, to allow patients to match
themselves, to make an informed choice from among a
menu of evidence-based treatment options. This may
not be feasible in smaller programs that may have few
staff members; however, in larger systems where more
than one treatment option can be provided, it would be
feasible to allow patients to choose for themselves.
Patient preference is increasingly being considered as
good practice in health care, such as when there are sev-
eral cancer treatment options available with similar
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overall evidence of efficacy. Patients can be given a fair de-
scription of the options open to them and permitted to
make an informed choice of which treatment they prefer.
It is still not clear if taking patient preferences into ac-
count when choosing between treatment options im-
proves treatment outcome. Authors of a systematic review
of the literature on shared decision making in treatment
of substance use disorder [26] reported that only 3 of 25
trials revealed a significant effect when treatments were
matched to patients’ preferences. The authors stated, how-
ever, that the results should be interpreted with caution
owing to heterogeneity of the included studies. One study
[27] showed that informed choice improved adherence
and reduced the amount of smoked cigarettes in a smok-
ing cessation intervention program for patients in treat-
ment for chemical dependency. On the contrary, a study
[28] of women with alcohol use disorder, who were given
the opportunity of choosing between individual therapy or
conjoint treatment with their male partner, showed that
the number of patients enrolled in treatment increased,
but there was no additional improvement in adherence or
reduced drinking days. The two groups also differed sig-
nificantly in sociodemographic variables that could influ-
ence outcome.
There are at least two good reasons for offering pa-
tients a choice when the treatment goal is behavior
change. The first is that patients are likely to have some
wisdom about which behavior change approach is most
likely to work for them. Who knows them better? They
certainly would know which approaches sound more ac-
ceptable or attractive to them. Second, there can be an
inherent motivational advantage of choosing one’s own
course of action. As Miller et al. stated,
When people perceive that they have freely selected,
from among options, a product or course of action,
they are likely to be more satisfied with it and
committed to it. There is evidence that taking active
steps toward change increases the likelihood of
successful change, no matter what the action happens
to be. If what matters is that the client do something
and stick with it, then it makes sense to allow clients to
select that to which they will be most committed [29].
To our knowledge, however, research is limited on the
benefit of having patients freely choose their treatment
approach from among options, in contrast to the usual
practice of their being assigned to a treatment based on
expert clinical judgment. Because there is little evidence
that clinical judgment is more effective than chance in
choosing optimal treatments, it is reasonable to conduct
a rigorous test of patient self-matching to determine
whether it does indeed improve retention, adherence,
and outcome in alcoholism treatment. As part of the
RESCueH studies [30], in the present randomized clin-
ical trial, we will compare the efficacy of patient self-
matching versus treatment-as-usual expert matching.
Purpose and hypotheses
The primary purpose of this randomized controlled trial
is to determine if patient self-matching to psychotherapy
treatment methods improves drinking outcome, compli-
ance, and quality of life for patients being treated for al-
cohol problems compared with assignment to treatment
as usual, which is by means of expert matching.
A priori hypotheses
Our a priori hypotheses are as follows:
1. Patients who choose their own treatment will show
significantly greater reductions in alcohol
consumption (measured by number of days with
excessive drinking) at follow-up, when compared with
patients assigned to treatment by expert matching.
2. Patients who choose their own treatment method
will show significantly better compliance in
treatment (measured by retention) when compared
with patients assigned to a specific treatment
method by expert matching.
Methods/design
Study design
The present study is being conducted as a randomized
controlled trial. Four hundred consecutive patients aged
18 years or older will be enrolled. All new patients ful-
filling the inclusion criteria will receive oral and written
information about the study.
Participants
All consecutive patients seeking treatment in the alcohol
treatment center in Odense, Denmark, will be offered
the opportunity to participate in the study if they meet
all of the inclusion criteria below:
1. Fulfill Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, criteria for alcohol abuse
or dependence
2. Aged 18 years or older
3. Danish- or English-speaking
4. Agree to participate in the study
The exclusion criteria were as follows:
1. Severe psychosis, measured by clinical interview
conducted by psychiatrist
2. Cognitive impairment, measured with the Mini
Mental State Examination
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Setting
Approximately 350 patients start treatment at the alco-
hol treatment center in Odense every year. Most pa-
tients are native Danish speakers. Treatment is provided
free of charge, and patients can stay anonymous unless
pharmacological treatment is needed. Patients are
assigned to one of five treatments according to an algo-
rithm that matches treatment to patient characteristics.
Treatment in the outpatient alcohol treatment center
The treatment center offers a range of treatment
courses. Patients can be referred for family therapy, cog-
nitive behavioral therapy, contract therapy, supportive
therapy, or netværket (the network). None of the treat-
ments includes group therapy, and all are provided on
an outpatient basis. Whereas family therapy, cognitive
behavioral therapy, contract therapy, and supportive
therapy are all based on regular sessions with a therapist,
netværket is a more informal treatment offer. Netværket
is open 4 days every week, offers the possibility of meet-
ing a therapist but also the possibility of meeting with
other patients and carrying out social activities together
such as gardening work and other activities. The contact
with therapists in netværket is relatively brief as com-
pared with the other treatment options. All treatment
options involve an interdisciplinary team of nurses,
psychiatrists, and social work professionals [31].
After psychiatric evaluation, the patients may also be
offered pharmacological treatment, including options of
disulfiram, naltrexone, acamprosate, and selective sero-
tonin reuptake inhibitors. This is the same for both the
self-match group and the expert match group, as well as
for patients not participating in the Self-Match Study.
The duration of treatment and frequency of sessions
follow the usual guidelines for outpatient alcohol treat-
ment at the treatment center. Therapists are well edu-
cated and trained, and they are experienced in the
treatment methods. Frequent supervision to secure ther-
apist fidelity to treatment method takes place. Clinical
guidelines are available for all treatment methods.
Usual referral routines
On admission, patients may require detoxification treat-
ment or may be ambivalent about seeking treatment at
all. After withdrawal symptoms have abated and one or
two sessions of motivational interviewing have been
completed, patients will decide whether to receive any
treatment for their alcohol use disorder.
For those who wish to receive further treatment, the
first baseline interview is carried out. Patients will re-
ceive oral and written information about the Self-Match
Study and then decide whether they want to participate.
Patients who agree to participate are randomized to ei-
ther self-matching or expert matching. All patients,
regardless of whether they agree to participate, will have
personality traits measured using the NEO Five-Factor
Inventory 3 (NEO-FFI-3) [32].
At the second baseline interview, patients’ sociodemo-
graphic data, alcohol consumption in the last 30 days,
and prior treatment history are clarified. These data are
used in the algorithm for expert matching. This inter-
view is also mandatory regardless of whether patients
participate in the Self-Match Study because the data are
used to plan specific treatment sessions in all the treat-
ment offers. Furthermore, this design ensures that expert
matching is treatment as usual. All treatment methods
in the study are part of the normal treatment modalities
offered at the center, which means that patients who
choose not to participate in the study will receive the
same treatment as participants. They are assigned to
treatment by algorithm as usual.
Experimental referral routines
Self-matching At the first baseline interview, the five
treatment options that are offered by the treatment cen-
ter are presented to patients in a short video presenta-
tion conducted by the first author. The content of the
videos was transcribed and analyzed for readability (LIX
number). All five presentations were scored at the same
LIX number of 44. The first author or a research assist-
ant will answer any further questions about the format
of all treatment options, logistics, and other aspects, but
no specific choice of either of the treatment options will
be or recommended or favored. The first author or a re-
search assistant will stress that all five treatment
methods are evidence-based and effective, at least for
some patients. As quality assurance, patients will
complete a questionnaire regarding the information they
received when asked to make a choice.
Study procedures
Information about the study will be presented when the
potential participant first attends the treatment center. If
the patient needs treatment for withdrawal symptoms,
the information will not be given until those symptoms
have been sufficiently treated.
The baseline interview is divided into two sessions to
avoid fatigue during a long assessment. This is already
standard procedure in the clinic for everyone receiving
treatment, regardless of participation in the study. Upon
providing written and oral consent, patients are random-
ized to either choosing their own treatment from among
five options or being assigned to one of these options by
means of the algorithm and expert opinion. Patients par-
ticipating in the study will be reinterviewed 6 months
after initiation of treatment. For an overview, see the
Standard Protocol Items: Recommendations for
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Interventional Trials (SPIRIT) in Fig. 1, the flowchart in
Fig. 2, and the SPIRIT checklist in Additional file 1.
Getting patients to participate in studies and getting a
high follow-up rate is usually an obstacle in research;
thus, we have designed the study routines as similarly as
possible to the usual assessment routines in the partici-
pating treatment institution. The only difference in par-
ticipation is the 45-minute follow-up interview. To
ensure a high follow-up rate, we are collecting phone
numbers as well as e-mail and home addresses of pa-
tients and their next of kin. If patients decide to remain
anonymous, we underline the importance of their re-
sponsibility to contact the treatment center 6 months
after treatment start.
Randomization and blinding Patients are assigned to
conditions by REDCap (Research Electronic Data Cap-
ture) from the Odense Patient Data Explorative Network
(OPEN), a computer-based randomization system. The
interviewer in charge of the first baseline interview will
activate the randomization when the patient has agreed
to participate in the study. The patient witnesses the
randomization, and the result is revealed immediately.
A case report for each participant will be prepared and
labeled with the participant’s number. All case reports
will be stored in a locked storage facility inaccessible to
the therapists, who are to remain uninformed of how
patients were assigned to treatment. Patients are urged
not to reveal their group assignment.
Data
The following instruments will be administered to pro-
vide standardized measures of alcohol problems, quality
of life, and personality traits:
 The Addiction Severity Index (ASI) is an assessment
tool for addiction problems [33].
 Timeline Followback is an assessment tool for
measuring the number of drinking days during the
preceding 30 days [34].
 The 26-itemWorld Health Organization Quality of
Life questionnaire [35]
 NEO-FFI-3 is a tool for measuring personality traits
[36].
 The Personal Happiness Form is a tool for assessing
well-being [37].
These validated and widely used instruments will allow
direct comparisons with mainstream clinical trials.
Statistical analyses and sample size
A multiple regression model will be used to model the
percentage of days with drinking/excessive drinking. If
the model validation shows that Gaussian multiple re-
gression does not fit owing to severely nonnormal data,
a multiple quantile regression model will be used in-
stead. Both modeling approaches allow for inclusion of
additional confounders. A backward elimination strategy
will be employed to identify significant explanatory vari-
ables using a significance level of 0.05. Generally, the
two-sided alternative will be considered, except when
comparing self-matching with expert matching. In the
latter case, a one-sided alternative will be used. Explana-
tory variables considered will include age, sex, and other
relevant available variables.
Power calculation
To our knowledge, no similar experimental studies have
been conducted. The power calculation is therefore
Fig. 1 Standard Protocol Items: Recommendations for Interventional
Trials: content for the schedule of enrollment, interventions, and
assessments. NEO-FFI-3 NEO Five-Factor Inventory 3, WHOQOL-BREF
26-item World Health Organization Quality of Life questionnaire
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estimated from what clinicians regard to be a clinically
meaningful difference in outcome. Miller and Manuel
[38] found that clinicians estimated the difference be-
tween two treatment methods to be meaningful for im-
plementation in daily practice if the continuous outcome
measures (e.g., number of days with excessive drinking)
were halved. The power calculation is based on the
number of days with excessive alcohol abuse over the
last 30 days after 6 months of treatment.
Currently, patients at the participating outpatient
clinic drink excessively, on average, 5.7 days (SD 9.7)
over the last 30 days after 12 months of treatment. With
the new methods for assigning treatment to patients, we
seek to halve the number of days with excessive drinking
to an average of 5.7/2 = 2.85 days (i.e., a reduction of 2.
85 days). We assume the SD will be the same for the re-
duced number of days. Most likely it will be smaller, be-
cause less than zero days of excessive drinking is
impossible; that is, the method is conservative. As stated
by Miller and Manuel [38], this power calculation is
based on practitioners’ judgment of a meaningful differ-
ence in outcome rather than on statistical significance
based on other studies. By this approach, a total sample
of 200 patients in each group is needed to have 90%
power to detect a difference of this magnitude using a
0.05% level of statistical significance (Fig. 3). We expect
that the proportion of patients assigned to each of the
five treatments will differ between the two groups;
hence, type of treatment, sociodemographic data, and
problem severity will be integrated into the analysis as
explanatory variables.
Fig. 2 Consolidated Standards of Reporting Trials 2010 flow diagram
Fig. 3 Power calculation
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Outcome measures
For each outcome measure, two analyses will be carried
out:
1. Intention-to-treat analyses (ITT) will be carried out
on all patients, regardless of whether they complete
the interventions or are reinterviewed. Regarding
incomplete data, multiple imputation will be used
together with ITT, but there will be some caveats.
2. Completer (on-treatment) analyses will be carried
out on patients who complete the respective
interventions.
The results will be published, regardless of the findings.
Primary outcome The primary outcome of the study is
the number of excessive drinking days 6 months after
initiation of treatment.
Secondary outcomes The secondary outcomes of the
study are as follows:
1. Compliance as measured by retention: At 6-month
follow-up, the number of sessions attended will be
measured
2. Quality of life
Deviations in chosen treatment in the self-matching
group in relation to anticipated expert matching will be
controlled for. In addition, the influence of personality
traits on outcome will be explored in both groups.
Discussion
The debate on matching patients to treatment has been
going on for decades. Several studies, including Project
MATCH [6] and UKATT [10], have shown that matching
patients to treatment is little better than chance, and they
have not been able to clarify which aspects of matching
improve outcome. In the present study, we will investigate
the importance of patient personal choice rather than clin-
ician matching patient to treatment based on patient char-
acteristics. Hence, the present study will cast light on
whether patients’ perceived autonomy yields better treat-
ment outcome. In addition, personality traits will be mea-
sured to investigate whether they influence the impact of
patients’ free choice on treatment outcome.
Challenges
On the basis of a pilot study of 16 patients that showed
a higher preference for supportive therapy in the self-
matching group than in the expert matching group, we
expect that the proportion of patients assigned to the
five treatments may differ between the two groups. This
will be controlled for in the analysis to clarify whether it
is the therapy method or self-matching that causes any
observed difference in outcome.
Some would argue that 50% reduction in excessive
drinking days is optimistic and therefore would criticize
the power calculation. The power calculation is based on
clinicians’ estimation of what would constitute a clinic-
ally meaningful outcome, however, rather than on statis-
tical significance derived from former studies.
Innovative aspects
All patients who seek treatment at the center will undergo
exactly the same intake procedure, including baseline in-
terviews, for this study. This procedure will provide an
opportunity to generate a hypothesis of motives to partici-
pate or not participate in studies, because the difference
between participating or not is reduced to a single 6-
month follow-up interview that will take about 45 minutes
to complete. Another innovative aspect is that personality
traits will be compared with outcomes in both groups and
thereby will provide information on any differences in per-
sonality traits of those who profit from self-matching and
those who profit from expert matching.
Trial status
The second version of the protocol was accepted on 17
November 2016. The study was accepted by the Regional
Scientific Ethical Committee for Southern Denmark on
24 March 2017. Recruitment began on 22 May 2017 and
is expected to end on 30 June 2019. There is currently
196 subjects enrolled and 62 of 69 subjects have partici-
pated in the follow up interview.
Additional file
Additional file 1: SPIRIT 2013 checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 121 kb)
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